Evaluation of Oxaliplatin and Gemcitabine in Patients With Metastatic Bladder Cancer

NCT04039867 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Trial was terminated due to halt in funding.

Conditions

Carcinoma, Transitional Cell

Interventions

DRUG: Oxaliplatin with Gemcitabine

Sponsor

University of California, Irvine